Position in RCUS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,754,104
+$3,426,698 QoQ
Shares Held
312,690
+123.9% QoQ
Ownership
0.249%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 99.71217499760145.ToString("F0")%
Shared 0.ToString("F0")%
None 0.2878250023985417.ToString("F0")%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $5,502,861,072 across 315 Biotechnology names. RCUS ranks #89 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,992,577 | $659,283,951 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
812,236 | $627,566,023 | |
| 3 | MRNA |
Moderna, Inc.
|
9,086,404 | $461,589,323 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
5,857,629 | $439,849,361 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
3,120,631 | $231,738,058 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
378,146 | $168,857,314 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,558,807 | $151,593,980 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
4,432,142 | $144,221,900 |
All Filings in RCUS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,754,104 | 312,690 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,327,406 | 139,631 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,412,699 | 471,522 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,322,707 | 408,195 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,342,628 | 298,424 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,184,154 | 146,686 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,074,226 | 135,659 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,601,099 | 105,128 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,970,669 | 263,277 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,159,694 | 113,073 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $757,759 | 42,215 | Shares | Sole | 2023-11-14 | |
| 2022-09-30 | $1,305,148 | 49,891 | Shares | Sole | 2022-11-14 | |
| 2021-12-31 | $6,488,797 | 160,336 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,386,677 | 68,445 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,782,669 | 137,752 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $951,041 | 33,869 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,301,888 | 204,233 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $10,145,954 | 591,946 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $9,087,447 | 367,318 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $753,281 | 54,271 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||